Clinical Trials Logo

Filter by:
NCT ID: NCT06246890 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

Autism ALERT Expansion

Start date: January 30, 2024
Phase:
Study type: Observational [Patient Registry]

Autism Access Link for Early Referral and Treatment [ALERT], the intervention proposed in this application, is a novel state-wide referral and case management platform that PCPs can activate to ensure that a child with suspected ASD receives all necessary ASD diagnosis and treatment resources in a single referral, radically simplifying a complex diagnostic and treatment process. We hypothesize that Autism ALERT will have strong acceptability and high rates of use among primary care providers as well as among diverse low-income parents of children at risk for ASD, and that we will see increased rate of child ASD educational evaluations within six months, and shortened time between referral and ASD treatment.

NCT ID: NCT06246812 Completed - Physical Inactivity Clinical Trials

Text Message and Competition-Based Interventions Among University Students

Start date: September 19, 2022
Phase: N/A
Study type: Interventional

The goal of this quasi-experimental study is to assess and compare the effectiveness of text message interventions and a competition-based intervention and evaluate participants' acceptability and experiences in university students. The main questions it aims to answer are: 1. What are the effects of text message interventions and competition-based interventions on university students' physical activity levels, self-efficacy, self-regulation, social support, incentive motivation, and mental well-being? 2. What are participants' perceptions regarding their experience with and acceptability of text message interventions and competition-based interventions? Participants will 1. participate in a fitness competition 2. participate in a fitness competition and receive text messages 3. enroll in control group

NCT ID: NCT06246799 Not yet recruiting - Clinical trials for Type 2 Diabetes (Adult Onset)

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

Start date: July 2024
Phase: Phase 3
Study type: Interventional

The goal of this randomized, open labelled clinical trial is to examine the efficacy, durability, and mechanism of HbA1c reduction produced by the combination of pioglitazone plus tirzepatide versus metformin plus sitagliptin in recently diagnosed type 2 diabetes mellitus patients. The main question[s] it aims to answer are: How effective is the combination of pioglitazone plus tirzepatide in managing blood sugar levels in people with type 2 diabetes? How does this combination compare to the use of metformin plus sitagliptin in controlling blood sugar levels? Participants will receive Pioglitazone beginning at 15 mg daily and ending 45 mg daily. (15mg month 1, 30mg month 2 and 45mg at month 3 onwards)

NCT ID: NCT06246786 Not yet recruiting - Clinical trials for Triple Negative Breast Cancer

Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)

Start date: July 2024
Phase: Early Phase 1
Study type: Interventional

This will be a single arm, non-randomized, pre-surgical clinical trial of women with newly diagnosed triple negative breast cancer with high g-H2Ax (gamma H2AX antibodies) comparing changes in biomarkers from a diagnostic core needle biopsy to surgical pathology specimen or repeat core needle biopsy.

NCT ID: NCT06246773 Not yet recruiting - Homelessness Clinical Trials

Feasibility of a Positive Parenting Program for Women Experiencing Homelessness Who Have a History of Interpersonal Violence

Start date: February 19, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to strengthen the skills and self-efficacy of women by addressing the social and emotional trauma that they have experienced from interpersonal violence (IPRV) and homelessness and to promote positive parenting strategies through Play and Learning Strategies (PALS), an evidence based intervention.

NCT ID: NCT06246747 Completed - Parkinson Disease Clinical Trials

The Use of Telerehabilitation to Improve Movement Outcomes for Patients With Parkinson Disease

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

The goal of this pilot randomized clinical trial was to assess the feasibility of telerehabilitation (TR) for patients with Parkinson's Disease (PD). The main questions it aims to answer are: 1. whether the recruitment to such a study will be successful and the satisfaction of both participants and clinicians will be good. 2. Clinical effectiveness of TR for patients with PD was also explored. Participants were randomized to 3 groups : 1. Clinic+TR. 2. TR-only group and 3. A usual control group. Results were compared between the groups.

NCT ID: NCT06246734 Recruiting - Dementia Clinical Trials

Companion Robotic Pets and Older Adults

Start date: March 3, 2024
Phase: N/A
Study type: Interventional

This research will assess the effect of companion robotic pets on the wellbeing of older adults and their family caregivers.

NCT ID: NCT06246539 Not yet recruiting - Clinical trials for Wellness, Psychological

Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

Burnout shares symptoms with anxiety and depression. While there is no single intervention for burnout, there are validated interventions (which are amenable to virtual reality (VR)) for anxiety and depression. UMassMemorial data from the Professional Well-Being Academic Consortium show that MD burnout and distress has increased since 2020. The investigators believe providing clinicians with a unique tool (VR) will be a feasible and efficacious way to tackle distress. It is known that only 1% of our MDs have done mindfulness training but nearly 50% are interested in doing so. Therefore, a self-administrable, interactive mindfulness program delivered over VR has great potential to reach clinicians who want to practice a more active form of mindfulness at a time convenient to them. The results of the study will provide preliminary evidence to determine if a take-home VR mindfulness program decreases clinician stress.

NCT ID: NCT06246526 Recruiting - Pain Clinical Trials

Real-World Efficacy of Evoke® Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA).

Start date: January 30, 2024
Phase: N/A
Study type: Interventional

This observational, prospective data collection is designed to evaluate the efficacy of CL-SCS therapy in real-world patients suffering from chronic pain.

NCT ID: NCT06246513 Recruiting - Clinical trials for Limb-girdle Muscular Dystrophy

A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4 (EMERGENE)

Start date: January 15, 2024
Phase: Phase 3
Study type: Interventional

This is a multicenter, global study of the effects of a single systemic dose of SRP-9003 on beta-sarcoglycan (β-SG) gene expression in participants with limb-girdle muscular dystrophy, type 2E/R4 (LGMD2E/R4). This study will consist of both ambulatory participants (Cohort 1) and non-ambulatory participants (Cohort 2).